NVO
Novo Nordisk A/SStock · Health CareMSCI EAFE 0.6% · MSCI World 0.2% · MSCI ACWI 0.1% · US Stock Market 0.0000%$43.24+0.12%
as of market close, Sep 18, 2026
☀ Pre $40.70 -5.87%
NVO — Novo Nordisk A/S price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDDDDDDDDDSDDDDDD
20.040.060.080.0100.0120.0140.00100.0M200.0M$43.24—20162019202120242026
2026-09-18
Price$43.24
MA20$45.18
MA50$48.66
Vol43.8M
Key stats
Price data
- Price
- $43.24
- Change YTD
- -15.02%
- Next earnings
- Nov 4, 2026
- Market cap
- 192.2B
- Enterprise value
- 207.1B
- Shares outstanding
- 4.4B
- 52W low
- $35.12
- 52W high
- $64.16
- From 52W high
- -32.61%
- From 52W low
- +23.12%
- 52W range
- 28%
- Beta
- 0.74
Volume
- Rel volume
- 0.98×
- 30D volume
- 10.5M
- 30D $ vol
- 480.8M
Fundamentals
- Sales (ttm)
- 46.6B
- Sales/share
- $10.50
- EPS (ttm)
- $3.48
- FCF (ttm)
- 18B
- FCF/share
- $4.05
- Book value/share
- $6.87
- Net margin
- 33.14%
- ROE
- 50.62%
- ROA
- 18.09%
- Debt / equity
- 0.57×
- Current ratio
- 0.80
Growth (CAGR, ttm) · 10Y
- Sales
- +10.85%+23.09%+19.16%n/a
- Net income
- +5.65%+25.36%+19.13%n/a
- Shares
- +0.07%-0.42%-1.11%n/a
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +6.00%+26.25%+20.34%n/a
- Sales/share
- +10.78%+23.60%+20.51%n/a
- Book value/share
- +52.70%+37.05%+25.46%n/a
- Dividend/share
- +6.90%+26.31%+20.47%n/a
- Price
- -30.11%-22.61%-3.13%+6.49%
- Total return
- -26.61%-20.34%-0.94%+8.90%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 12.4×
- P/OI (ttm)
- 10.0×
- Fwd P/E
- 12.3×
- P/S (ttm)
- 4.1×
- P/B (mrq)
- 6.3×
- P/FCF (ttm)
- 10.7×
- EV/EBITDA (fy)
- 9.6×
- EV/Sales (ttm)
- 4.4×
- FCF yield (ttm)
- 9.36%
- Dividend yield (fwd)
- 4.08%
- Dividend/share (fwd)
- $1.77
- Buyback yield (realized, 1y)
- -0.07%
- Shareholder yield (realized, 1y)
- 1.98%
- Buyback yield (cash, ttm)
- 0.11%
- Shareholder yield (cash, ttm)
- 4.17%
Vs own 10Y history
- P/E
- 4th
- P/OI
- 4th
- P/S
- 4th
- P/B
- 4th
Bar = where today’s multiple sits in NVO’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-09-18
1D
+0.12%
5D
+0.39%
1M
-5.40%
3M
+0.12%
YTD
-15.02%
1Y
-30.09%
5Y
-14.72%
Financial statements
Open full NVO financials →Loading financial statements…
Related Health Care
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| NVS | Novartis AG | -9.18% | -0.39% |
| SNY | Sanofi ADS | -5.54% | -1.53% |
| GSK | GSK plc American Depositary Shares (Each representing two Ordinary Shares) | -1.82% | -1.65% |
| ARGX | argenx SE American Depositary Shares | -0.27% | -0.55% |
| TAK | Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | +4.76% | -0.73% |
| NTRA | Natera Inc. | +18.51% | +0.84% |
| TEVA | Teva Pharmaceutical Industries Limited American Depositary Shares | +6.56% | -0.54% |
| RVMD | Revolution Medicines Inc. | -11.60% | -3.04% |
Novo Nordisk A/S (NVO) trades at $43.24 with a live price and an interactive chart covering 45+ years of daily price history, plus key valuation metrics. ChartRow also publishes NVO’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full NVO financial statements →
